Sio Capital Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-12,972
| Closed | -$102K | – | 56 |
|
|
2022
Q3 | $102K | Sell |
12,972
-32,350
| -71% | -$254K | 0.03% | 38 |
|
|
2022
Q2 | $952K | Hold |
45,322
| – | – | 0.36% | 41 |
|
|
2022
Q1 | $1.7M | Hold |
45,322
| – | – | 0.56% | 38 |
|
|
2021
Q4 | $2.55M | Hold |
45,322
| – | – | 0.77% | 34 |
|
|
2021
Q3 | $3.27M | Buy |
45,322
+1,887
| +4% | +$136K | 1.04% | 31 |
|
|
2021
Q2 | $4.16M | Buy |
43,435
+23,750
| +121% | +$2.28M | 1.03% | 34 |
|
|
2021
Q1 | $2.91M | Buy |
19,685
+5,000
| +34% | +$739K | 0.59% | 52 |
|
|
2020
Q4 | $2.05M | Sell |
14,685
-534
| -4% | -$74.7K | 0.42% | 64 |
|
|
2020
Q3 | $2.31M | Buy |
15,219
+6,249
| +70% | +$948K | 0.46% | 51 |
|
|
2020
Q2 | $1.58M | Buy |
+8,970
| New | +$1.58M | 0.46% | 50 |
|